Altre lingue Cosmo Pharmaceuticals N.V.

Azioni

Mercato chiuso - Swiss Exchange Altri mercati azionari 17:30:02 17/05/2024			Variaz. 5gg	Var. 1 gen.
72,9 ^CHF	-0,82%		+2,97%	+43,22%

26/04	Cosmo Pharmaceuticals N.V. annuncia cambiamenti esecutivi in occasione della prossima Assemblea Generale Annuale del 24 maggio 2024	CI
25/04	Cosmo Pharmaceuticals nomina un nuovo amministratore delegato, presidente	MT

Cosmo Pharmaceuticals N : Niall Donnelly CV	09/05
Cosmo Pharmaceuticals N : Convening notice	09/05
Cosmo Pharmaceuticals N : Written Proxy	09/05
Cosmo Pharmaceuticals N : Explanatory notes	09/05
Cosmo Pharmaceuticals N : Notification of number of shares	09/05
Cosmo Pharmaceuticals N : Alessandro Della Chà CV	09/05
Cosmo Pharmaceuticals N : Giovanni Di Napoli CV	09/05
Cosmo Pharmaceuticals N : John O’Dea CV	09/05
Cosmo Pharmaceuticals N : Maria Grazie Roncarolo CV	09/05
Cosmo Pharmaceuticals N : Mauro S. Ajani CV	09/05
Cosmo Pharmaceuticals N : Nail Donnely CV	09/05
Cosmo Has Received Approval of an Extension in Respect of the Publication and the Filing of Its Annual Report 2023	29/04
Cosmo darf definitive Jahresrechnung 2023 bis Ende Mai veröffentlichen	29/04
Cosmo pourra publier ses résultats 2023 définitifs d'ici au 31 mai	29/04
Cosmo Pharmaceuticals N : has received approval of an extension in respect of the publication and the filing of its annual report 2023	29/04
Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	26/04
Cosmo Pharmaceuticals Names New CEO, Chairman	25/04
Changements à la tête de Cosmo	25/04
Cosmo ernennt Giovanni Di Napoli zum neuen CEO - Della Chà wird VR-Präsident	25/04
Cosmo Announces Leadership Changes	25/04

Non ci sono risultati per questa ricerca